• Eltanexor Inhibits XPO1 to Suppress Wnt/β-Catenin in CRC Mod

  2026-06-19

  The referenced study demonstrates that Eltanexor (KPT-8602), a second-generation XPO1 inhibitor, significantly reduces colorectal cancer tumorigenesis by modulating Wnt/β-catenin signaling and suppressing COX-2 expression. These findings highlight the translational potential of XPO1-targeted therapies for chemoprevention in high-risk colorectal cancer populations.

• Nifedipine (BAY-a-1040): Applied Workflows in Calcium and Ir

  2026-06-19

  Nifedipine (BAY-a-1040) from APExBIO empowers precise inhibition of L-type calcium channels in diverse research models, unlocking new insights into calcium-dependent signaling and iron metabolism. This article delivers actionable, protocol-driven strategies for maximizing assay reproducibility and experimental value, with special attention to troubleshooting and emerging cross-domain applications.

• Hydrocortisone (SKU B1951): Technical Guide for Research Use

  2026-06-18

  Hydrocortisone (SKU B1951) is a benchmark glucocorticoid hormone for dissecting anti-inflammatory pathway modulation, stress response mechanisms, and glucocorticoid receptor signaling. This guide details practical handling, solubility, and QC steps for robust use in inflammation model research and neuroprotection workflows. It is not intended for use in clinical or diagnostic settings, nor should it be substituted for therapeutic-grade material.

• Filipin III: Advanced Cholesterol Detection in Membrane Assa

  2026-06-18

  Filipin III, a polyene macrolide antibiotic, is the gold-standard fluorescent probe for mapping cholesterol in biological membranes. This article translates recent breakthroughs and troubleshooting strategies into actionable workflows for cell biologists and membrane researchers, with a focus on PHMG-induced pulmonary fibrosis and beyond.

• Hydrocortisone in Experimental Research: Applied Protocols a

  2026-06-17

  Hydrocortisone stands out as a gold-standard glucocorticoid hormone for dissecting inflammation, barrier function, and cancer stem cell biology. This article delivers actionable workflows and troubleshooting insights for maximizing reproducibility and translational relevance in preclinical models, highlighting cutting-edge findings and practical enhancements.

• L-NAME Hydrochloride: Precision NOS Inhibition for Vascular

  2026-06-17

  L-NAME Hydrochloride (NG-nitro-L-arginine methyl ester) empowers researchers to dissect nitric oxide signaling in cardiovascular models, enabling robust modulation of vascular tone, apoptosis, and inflammation. Its validated potency and versatility make it a premier choice for both cellular and whole-animal workflows, supporting reproducibility in hypertension and endothelial dysfunction research.

• QRICH1 Drives ER Stress-Mediated HMGB1 Secretion in HBV Fibr

  2026-06-16

  This study uncovers QRICH1 as a pivotal effector in endoplasmic reticulum (ER) stress pathways that enhance HBV-induced HMGB1 translocation and secretion in hepatocytes. By elucidating the molecular interplay between QRICH1, SIRT6 modulation, and HMGB1 activity, the work advances our understanding of inflammatory mechanisms underlying hepatic fibrosis and highlights novel directions for experimental modeling.

• HYPK Accelerates NatA Ribosome Exchange to Enable Global Ace

  2026-06-16

  Lentzsch et al. (2025) reveal that Huntingtin-interacting protein K (HYPK) is essential for the efficient N-terminal acetylation of the eukaryotic proteome by acting as a ribosome exchange factor for N-terminal acetyltransferase A (NatA). This study clarifies how limited NatA can rapidly modify numerous nascent proteins in vivo, uncovering a key regulatory mechanism in cotranslational protein maturation.

• CCG-1423: Redefining RhoA Inhibition for Tight Junction and

  2026-06-15

  Explore the scientific depth of CCG-1423, a potent RhoA inhibitor, and its pivotal role in dissecting tight junction dynamics and apoptosis in cancer and viral models. This article delivers unique insights drawn from recent mechanistic research and practical workflow guidance.

• Dual-Action p38α MAPK Inhibition: Conformational Mechanisms

  2026-06-15

  The referenced study reveals a novel dual-action mechanism for certain p38α MAP kinase inhibitors: they not only block kinase activity but also accelerate dephosphorylation by promoting a phosphatase-accessible conformation. This insight suggests new strategies for achieving greater selectivity and potency in targeting inflammation and cytokine signaling pathways.

• MTT: Mechanistic Insights and Innovations for In Vitro Assay

  2026-06-14

  Explore the molecular mechanisms and advanced decision-making enabled by MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) in in vitro cell proliferation assays. Uncover how mechanistic evidence and workflow optimization set a new benchmark for metabolic activity measurement.

• Vacuolin-1: Advancing Lysosomal Exocytosis Inhibition in Car

  2026-06-13

  Explore how Vacuolin-1, a leading lysosomal exocytosis inhibitor, enables precise dissection of lysosome-mediated membrane trafficking and cartilage pathology. Delve into advanced protocols and new insights that differentiate this guide from previous resources.

• DiR (DiIC 18 (7)) for Long-Term Membrane Tracking and EV Ima

  2026-06-12

  DiR (DiIC 18 (7)) enables high-sensitivity, long-duration labeling of cell membranes and extracellular vesicles, dramatically improving in vivo imaging and cell tracking. Its near-infrared fluorescence and robust membrane retention empower advanced workflows, including MPS evasion strategies and regenerative medicine applications.

• GSK J4 HCl: Strategic Epigenetic Inhibition for Translationa

  2026-06-12

  Explore how GSK J4 HCl, a potent JMJD3 inhibitor from APExBIO, is reshaping translational research in inflammation, cancer, and immune modulation. This article synthesizes mechanistic insights and actionable guidance, anchored in the latest evidence and best practices, to help researchers accelerate discovery and model complex disease processes.

• CX-5461: RNA Polymerase I Inhibitor Transforming Cancer Rese

  2026-06-11

  CX-5461 from APExBIO empowers researchers to target ribosome biogenesis for selective solid tumor growth inhibition and mechanistic insights into autophagy and cellular senescence. This guide translates the latest evidence into actionable workflows, troubleshooting advice, and advanced applications for maximizing the impact of this potent RNA polymerase I inhibitor.

11839 records 1/790 page Next 12345 下5页 Last page